As the canonical downstream effector of the PI3K-AKT oncogenic pathway, FoxO proteins are widely considered as tumor suppressors by inhibiting survival-related pathways, such as transactivating apoptotic genes Bim and PUMA [45–47]. Here, BCL2L11 is linked to neoplasm.